FDA Inspection 1345550 — Garonit Pharmaceutical, Inc.
The FDA completed an inspection of Garonit Pharmaceutical, Inc. on Oct 2, 2026 in Fairfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 2, 2026
- Fiscal Year
- 2027
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fairfield, NJ (United States)